Warmerdam, P.

screening mouse protein cancer mouse ercc breast programme sequence model breast cancer repair age range stage life years promoter life year interval women screening interval screen research figure region domain death policy distribution acids research result level screening programme number breast cancer screening difference homology nucleotide study state position analysis effectiveness treatment 43-3 yeast probe koning hj mortality breast screening programme range clone expression evolution amphotericin dna-binding domain excision function genomic computer life histories modelled group c-terminal stage distribution effect van oortmarssen gj toxicity health 43-3 b cells hybridization cost effectiveness phase screening policies amphotericin b pcd 3c sv 40 boer r patient mutation pcdemp mouse organs